Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Not Yet Recruiting

Multi-center Screening for Serum M Protein

NCT06750965

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

CAR-T Cell Therapy Combined With Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma

NCT06913179

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Efficacy of Sequential BCMA CAR-T Cell Therapy Following Autologous Hematopoietic Stem Cell Transplantation in Transplant-eligible Newly Diagnosed Multiple Myeloma

NCT06913192

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma

NCT06880601

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Multiple Myeloma is a Hematologic Malignancy Characterized by the Accumulation of Malignant Plasma Cells in the Bone Marrow. Despite Advances in Treatment, Many Patients Experience Disease Relapse. Bispecific Antibodies Offer an Innovative Therapeutic Approach, But Approximately 30%-40% of Patients

NCT06888856

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma

NCT06888752

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

"Vitamin C Deficiency in Hospitalized Adults: Systematic Screening Vs. Traditional Judgment - a Before-and-After Observational Study"

NCT06876545

Conditions: Ascorbic Acid Deficiency, Avitaminosis, Cardiovascular Diseases, +10 more
Locations: Gueret Hospital Guéret, Creuse, France

View Trial Details

Not Yet Recruiting

Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy

NCT06825845

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Bioequivalence Studies of Dasatinib 100 Mg

NCT05944783

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: CAIMED Chía, Cundinamarca, Colombia

View Trial Details

Not Yet Recruiting

Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer

NCT06817759

Conditions: Anxiety Disorders, Blood Cancer, Blood Protein Disorders, +24 more
Locations: Centre de Recherche de l'Hôpital Maissonneuve-Rosemont Montreal, Quebec, Canada

View Trial Details

Hemostatic Disorders

Hemostatic Disorders trial results

Related conditions